Rencofilstat
- Generic Name
- Rencofilstat
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C67H122N12O13
- CAS Number
- 1383420-08-3
- Unique Ingredient Identifier
- M3H4D91AY5
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-06-02
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Hepion Pharmaceuticals, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT05402371
- Locations
- 🇺🇸
Entrust Clinical Research, Miami, Florida, United States
🇺🇸United Reseach Group, Miami, Florida, United States
🇺🇸Synergy Healthcare, LLC, Bradenton, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath